Tran-Scell Biologics is planning to set up a stem cell research-cum-therapeutic facility in Hyderabad.
The company will be investing about Rs 380 crore for the proposed facility.
The project to be developed in phased manner will have a hospital with 180 beds in the Phase I at an investment of Rs 140 crore. While the hospital will be ready by early 2012, the entire project is slated to be completed by December 2012. Research at the facility will primarily focus on diabetes, knee-replacement and spinal cord injuries.
